Clincosm LogoSign in Get a demo

gastric cancer

Showing NaN - NaN of 116
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, Advanced Cancer, Metastatic Cancer Trial in China, United States (TJ033721)

Recruiting
  • Solid Tumor
  • +6 more
  • Orange, California
  • +17 more
Aug 9, 2022

Gastric Cancer Trial in China, Korea, Republic of, United States (IDX-1197+XELOX, IDX-1197+Irinotecan)

Recruiting
  • Gastric Cancer
  • Los Angeles, California
  • +11 more
Aug 7, 2022

Gastric Cancer, GastroEsophageal Cancer Trial in China (SHR-1210, Capecitabine, Oxaliplatin)

Completed
  • Gastric Cancer
  • GastroEsophageal Cancer
  • SHR-1210
  • +3 more
  • Hefei, Anhui, China
  • +9 more
Jun 30, 2022

Use of Circulating Exosomal LncRNA-GC1 to Monitor Gastric Cancer

Recruiting
  • Gastric Cancer
  • Measurement of levels of circulating exosomal lncRNA-GC1
  • Beijing, Beijing, China
    Xinxin Wang
Jun 24, 2022

Gastric Cancer Trial in Worldwide (Nivolumab, Tegafur-gimeracil-oteracil potassium, Oxaliplatin)

Active, not recruiting
  • Gastric Cancer
  • Anhui Province, China
  • +107 more
May 22, 2022

NSCLC, Gastric Cancer, Hepatocellular Carcinoma Trial in Beijing, Shanghai (natural killer T cell)

Recruiting
  • Non-small Cell Lung Cancer
  • +3 more
  • natural killer T cell
  • Beijing, China
  • +1 more
Apr 26, 2022

Gastric Cancer, Gastroesophageal Junction Cancer Trial in Worldwide (BBI608, Paclitaxel, Placebo)

Completed
Has Results
  • Gastric Cancer
  • Gastroesophageal Junction Cancer
  • Scottsdale, Arizona
  • +262 more
Apr 4, 2022

Breast Cancer, Gastric Cancer, Gastroesophageal Junction Cancer Trial in China, Korea, Republic of, Taiwan (ZW25, Docetaxel,

Active, not recruiting
  • Breast Cancer
  • +2 more
  • ZW25
  • +4 more
  • Beijing, Beijing, China
  • +21 more
Apr 1, 2022

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in China (Atezolizumab, Trastuzumab, Capecitabine)

Recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Beijing, China
  • +9 more
Mar 11, 2022

Advanced Solid Tumors, Gastric Cancer, Esophagogastric Junction Cancer Trial in Beijing (IM92 CAR-T cells)

Recruiting
  • Advanced Solid Tumors
  • +3 more
  • IM92 CAR-T cells
  • Beijing, Beijing, China
    Chinese PLA GENERAL HOSPITAL
Mar 10, 2022

Advanced Solid Tumor, Cholangiocarcinoma, Biliary Tract Cancer Trial in Beijing, Jinan, Shanghai (TT-00420, Combination Product:

Not yet recruiting
  • Advanced Solid Tumor
  • +10 more
  • Beijing, China
  • +3 more
Feb 14, 2022

Solid Tumor, Gastric Cancer, Pancreatic Adenocarcinoma Trial in China (AB011 Injection)

Recruiting
  • Solid Tumor
  • +2 more
  • AB011 Injection
  • Hefei, Anhui, China
  • +11 more
Feb 7, 2022

Gastric Cancer Trial in Beijing (neoantigen tumor vaccine with or without PD-1/L1)

Not yet recruiting
  • Gastric Cancer
  • neoantigen tumor vaccine with or without PD-1/L1
  • Beijing, China
    Department of GI Oncology, Peking University Cancer Hospital,
Jan 26, 2022

Gastric Cancer, Esophageal Cancer, Liver Cancer Trial in Beijing (neoantigen tumor vaccine with or without PD-1/L1)

Recruiting
  • Gastric Cancer
  • +2 more
  • neoantigen tumor vaccine with or without PD-1/L1
  • Beijing, Beijing, China
    PLA General Hospital
Jan 27, 2022

Gastric Cancer, Neoadjuvant Therapy Trial in Beijing (radiation, drug, procedure)

Recruiting
  • Gastric Cancer
  • Neoadjuvant Therapy
  • SIB-IMRT
  • +3 more
  • Beijing, China
    Department of Radiation Oncology, Cancer Hospital, Chinese Acade
Jan 20, 2022

Gastric Cancer, HER2 Overexpressing Gastric Carcinoma Trial in Beijing (RC48-ADC)

Completed
  • Gastric Cancer
  • HER2 Overexpressing Gastric Carcinoma
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Jan 12, 2022

Gastric Cancer, HER2 Overexpressing Gastric Carcinoma Trial in China (RC48-ADC, Paclitaxel injection, Irinotecan Hydrochloride

Recruiting
  • Gastric Cancer
  • HER2 Overexpressing Gastric Carcinoma
  • Beijing, Beijing, China
  • +51 more
Jan 6, 2022

Gastric Cancer Trial in Beijing (Sintilimab, Oxaliplatin, Capecitabine)

Active, not recruiting
  • Gastric Cancer
  • Beijing, Beijing, China
    The Fifth Medical Center,Chinese PLA General Hospital
Dec 14, 2021

Gastric Cancer Trial in Beijing (Radical gastrectomy with dissection of lower mediastinal lymph node)

Recruiting
  • Gastric Cancer
  • Radical gastrectomy with dissection of lower mediastinal lymph node
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Nov 21, 2021

Gastric Cancer, Esophagogastric Junction Disorder Trial in Beijing (Savolitinib)

Recruiting
  • Gastric Cancer
  • Esophagogastric Junction Disorder
  • Beijing, Beijing, China
    Beijing Cancer Hopspital
Aug 30, 2021

Gastric Cancer, GastroEsophageal Cancer Trial in Beijing (SHR-1210, Capecitabine, Oxaliplatin)

Active, not recruiting
  • Gastric Cancer
  • GastroEsophageal Cancer
  • Beijing, Beijing, China
    Beijing Cancer Hospital, Peking University
Aug 24, 2021

Gastric Cancer, Precancerous Lesion, Helicobacter Pylori Infection Trial in China (pepsinogen)

Recruiting
  • Gastric Cancer
  • +2 more
  • pepsinogen
  • Jilin, Jilin, China
  • +8 more
Jul 25, 2021

Multi-Omics Noninvasive Inspection of TumOr Risk for Gastric

Recruiting
  • Gastric Cancer
  • ctDNA multi-omics test
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Jun 24, 2021

Gastric Cancer, Colo-rectal Cancer Trial in Beijing (Tislelizumab, Anlotinib)

Recruiting
  • Gastric Cancer
  • Colo-rectal Cancer
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Mar 2, 2021

Gastric Cancer Trial in Beijing (camrelizumab, Apatinib Mesylate, Paclitaxel)

Unknown status
  • Gastric Cancer
  • Beijing, China
    Affiliated Hospital, Academy of Military Medical Sciences
Feb 20, 2021